> MTDH is important for most major human cancers, not important for normal cells, and it can be eliminated with no obvious side effects I'm not fully buying that. If you look at "Function" on Wikipedia, it seems to have some important roles, including angiogenesis (which is still important outside of cancer). It's not like evolution would select for something that is useless outside of helping cancer. I'd be curious…
You're challenging someone with 15 years experience studying this particular gene... by quoting Wikipedia?
New cancer therapy holds potential to switch off major cancer types
71–80 of 111 posts
Re: New cancer therapy holds potential to switch off major cancer types
#72> MTDH is important for most major human cancers, not important for normal cells, and it can be eliminated with no obvious side effects I'm not fully buying that. If you look at "Function" on Wikipedia, it seems to have some important roles, including angiogenesis (which is still important outside of cancer). It's not like evolution would select for something that is useless outside of helping cancer. I'd be curious…
Disclaimer: I’m not in these fields but I am curious enough about how the mechanisms work at a high level that I feel confident about the rest of this post. Two things to keep in mind: 1. Biology has never selected genes to maximize longevity, only to maximize healthy breeding. There are very likely tons of genes that make sense as a growing child but are harmful at a later age, e.g. a post menopause/vasectomy adult…
That is assumption which is hard to validate. There is a case for longevity as children with longer living dedicated parents in the context of abundant resources will out survive those that are ditched by their parents.
> Delete the notable gene or just make a point mutation to disable it.
The article say that effect is the same with deletion and drug in mice. Why would you delete the gene when you can temporally prevent its function ?
> Delete the notable gene or just make a point mutation to disable it. Treat/wait the cancer into remission.
Yet nobody did nothing remotely close in humans, even for stuff that looks like highly beneficial in all contexts such as GULO gene.
Re: New cancer therapy holds potential to switch off major cancer types
#73> MTDH is important for most major human cancers, not important for normal cells, and it can be eliminated with no obvious side effects I'm not fully buying that. If you look at "Function" on Wikipedia, it seems to have some important roles, including angiogenesis (which is still important outside of cancer). It's not like evolution would select for something that is useless outside of helping cancer. I'd be curious…
Angiogenesis is going to be important in wound healing, I suppose, but compared to the current side effects of chemo this seems relatively minor. I agree that "no obvious side effects" seems excessive if you interpret that as the expected result in humans. Still, on paper this looks much more specific that anything we have.
Re: New cancer therapy holds potential to switch off major cancer types
#74> MTDH is important for most major human cancers, not important for normal cells, and it can be eliminated with no obvious side effects I'm not fully buying that. If you look at "Function" on Wikipedia, it seems to have some important roles, including angiogenesis (which is still important outside of cancer). It's not like evolution would select for something that is useless outside of helping cancer. I'd be curious…
You're challenging someone with 15 years experience studying this particular gene... by quoting Wikipedia?
Re: New cancer therapy holds potential to switch off major cancer types
#75Earlier quoted context omitted.
> It's not like evolution would select for something that is useless outside of helping cancer. Cancers often have genetic basis so in a sense evolution has already selected for it in some people or at least not selected against it. IANAdoctor/biologist but i assume diseases that tend to strike after child bearing age have less negative selection pressure than other diseases.
> IANAdoctor/biologist but i assume diseases that tend to strike after child bearing age have less negative selection pressure than other diseases. It gets even better: there is selective pressure for adults that have borne children to die so that their children can procreate. First noted in pea plants that send a chemical signal to kill themselves up from the pod, can be extended to animals in things like cancer rat…
Re: New cancer therapy holds potential to switch off major cancer types
#76Earlier quoted context omitted.
> It's not like evolution would select for something that is useless outside of helping cancer. Cancers often have genetic basis so in a sense evolution has already selected for it in some people or at least not selected against it. IANAdoctor/biologist but i assume diseases that tend to strike after child bearing age have less negative selection pressure than other diseases.
> IANAdoctor/biologist but i assume diseases that tend to strike after child bearing age have less negative selection pressure than other diseases. It gets even better: there is selective pressure for adults that have borne children to die so that their children can procreate. First noted in pea plants that send a chemical signal to kill themselves up from the pod, can be extended to animals in things like cancer rat…
Re: New cancer therapy holds potential to switch off major cancer types
#77> MTDH is important for most major human cancers, not important for normal cells, and it can be eliminated with no obvious side effects I'm not fully buying that. If you look at "Function" on Wikipedia, it seems to have some important roles, including angiogenesis (which is still important outside of cancer). It's not like evolution would select for something that is useless outside of helping cancer. I'd be curious…
I know nothing about biology, medicine or evolution, but I don't think that's how it works. Lots of people inherit and pass on all kinds of bad genes that do terrible things to them, even kill them. And for such people, switching them off would be better pretty much irrespective of any side effects. (to the degree there even are any side effects at all)
well, by all means, don't let that stop you
Re: New cancer therapy holds potential to switch off major cancer types
#78Earlier quoted context omitted.
You're challenging someone with 15 years experience studying this particular gene... by quoting Wikipedia?
Ah the classic appeal-to-authority-fallacy ... https://yourlogicalfallacyis.com/appeal-to-authority
Re: New cancer therapy holds potential to switch off major cancer types
#79> MTDH is important for most major human cancers, not important for normal cells, and it can be eliminated with no obvious side effects I'm not fully buying that. If you look at "Function" on Wikipedia, it seems to have some important roles, including angiogenesis (which is still important outside of cancer). It's not like evolution would select for something that is useless outside of helping cancer. I'd be curious…
Disclaimer: I’m not in these fields but I am curious enough about how the mechanisms work at a high level that I feel confident about the rest of this post. Two things to keep in mind: 1. Biology has never selected genes to maximize longevity, only to maximize healthy breeding. There are very likely tons of genes that make sense as a growing child but are harmful at a later age, e.g. a post menopause/vasectomy adult…
Re: New cancer therapy holds potential to switch off major cancer types
#80> MTDH is important for most major human cancers, not important for normal cells, and it can be eliminated with no obvious side effects I'm not fully buying that. If you look at "Function" on Wikipedia, it seems to have some important roles, including angiogenesis (which is still important outside of cancer). It's not like evolution would select for something that is useless outside of helping cancer. I'd be curious…
The paper is talking about a compound (two compound candidates) that inhibit binding of two proteins: AEG-1 (encoded by MTDH) and SND1, those compounds do that by binding to either AEG-1’s or SND1’s site where otherwise SND or AEG-1 would have bind, and they likely do this with stronger bond than SND1 and AEG1 would have had.
So in short, this compound does not leave you without some vital protein but disrupt formation of some bonds with SND1 protein.